Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non-Small Cell Lung Cancer.
about
Epigenetic Regulation of the Epithelial to Mesenchymal Transition in Lung Cancer.Epigenetic mediated zinc finger protein 671 downregulation promotes cell proliferation and tumorigenicity in nasopharyngeal carcinoma by inhibiting cell cycle arrest.BETting on combination to overcome PARPi resistance.Modulation of antitumor immunity with histone deacetylase inhibitors.Chromatin dependencies in cancer and inflammation.Combination of a novel HDAC6 inhibitor ACY-241 and anti-PD-L1 antibody enhances anti-tumor immunity and cytotoxicity in multiple myeloma.Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment.Immunotherapy With Human Gamma Delta T Cells-Synergistic Potential of Epigenetic Drugs?Immune oncology, immune responsiveness and the theory of everything.Modeling combination therapy for breast cancer with BET and immune checkpoint inhibitorsAutochthonous murine models for the study of smoker and never-smoker associated lung cancers
P2860
Q38696030-564A372C-F1A6-47D3-99BD-03E0D1D3E249Q42668878-E647EBEC-C063-4E98-8A1D-BD57D13292FDQ47093793-6D5B52BD-BCB3-4732-8289-698576303D55Q49557954-355E59EB-0AD6-4310-81F6-6E29C744B6A9Q49565575-53C3F6A4-C3B7-4DB4-8BAA-DCC4AC6979B4Q50147664-66FB5A9B-C369-4AAE-A0C8-06CDB5875009Q52688134-9A80DB09-A1CE-471D-97D5-20C360575FD4Q55030400-FAB4ECD8-7BFA-4D1F-ADD8-832FC81720F7Q55487467-9EAAB52E-224E-4601-B406-2CBE836F5AAAQ56892267-7797AE46-F7E8-4E1B-8984-ED89E11F7AADQ58804389-A5607323-CE83-4E15-9D77-CFC6EF36C852
P2860
Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non-Small Cell Lung Cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Synergistic Immunostimulatory ...... in Non-Small Cell Lung Cancer.
@en
Synergistic Immunostimulatory ...... in Non-Small Cell Lung Cancer.
@nl
type
label
Synergistic Immunostimulatory ...... in Non-Small Cell Lung Cancer.
@en
Synergistic Immunostimulatory ...... in Non-Small Cell Lung Cancer.
@nl
prefLabel
Synergistic Immunostimulatory ...... in Non-Small Cell Lung Cancer.
@en
Synergistic Immunostimulatory ...... in Non-Small Cell Lung Cancer.
@nl
P2093
P2860
P50
P1433
P1476
Synergistic Immunostimulatory ...... in Non-Small Cell Lung Cancer.
@en
P2093
Amir R Aref
Christina Almonte
David A Barbie
Guo-Cheng Yuan
Haikuo Zhang
James Bradner
Jennifer L Guerriero
Jerome Ritz
Jessica Castrillon
Kwok-Kin Wong
P2860
P304
P356
10.1158/2159-8290.CD-16-1020
P577
2017-04-13T00:00:00Z